TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · IEX Real-Time Price · USD
1.890
+0.020 (1.07%)
Apr 26, 2024, 12:35 PM EDT - Market open
TherapeuticsMD Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for TherapeuticsMD stock has a target of 5.00, which predicts an increase of 164.55% from the current stock price of 1.89.
Analyst Consensus: Hold
* Price targets were last updated on Aug 17, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for TherapeuticsMD is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $5 | Hold | Reiterates | $5 | +164.55% | Aug 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $5 | Hold | Initiates | $5 | +164.55% | Jan 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $1 | Hold | Reiterates | $1 | -47.09% | Jul 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $10 | Strong Buy → Hold | Downgrades | $10 | +429.10% | Jun 7, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $250 → $50 | Buy → Hold | Downgrades | $250 → $50 | +2,545.50% | May 6, 2022 |
Financial Forecast
Revenue This Year
9.18M
from 1.30M
Increased by 605.07%
Revenue Next Year
9.28M
from 9.18M
Increased by 1.11%
EPS This Year
0.36
from -0.98
EPS Next Year
0.36
from 0.36
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 9.5M | 9.6M |
| Avg | 9.2M | 9.3M |
| Low | 8.8M | 8.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 625.8% | 4.1% |
| Avg | 605.1% | 1.1% |
| Low | 577.4% | -2.9% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | 0.37 | 0.37 |
| Avg | 0.36 | 0.36 |
| Low | 0.34 | 0.34 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | 2.9% |
| Avg | - | - |
| Low | - | -3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.